# Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access

> **NCT05124184** · — · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 356 (actual)

## Conditions studied

- PAD - Peripheral Arterial Disease
- AAA - Abdominal Aortic Aneurysm
- End-Stage Renal Disease

## Interventions

- **DEVICE:** GORE® PROPATEN® Vascular Graft
- **DEVICE:** GORE-TEX® Vascular Grafts

## Key facts

- **NCT ID:** NCT05124184
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-24
- **Primary completion:** 2024-07-22
- **Final completion:** 2024-07-22
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05124184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05124184, "Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05124184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*